Abbott MediaRoom (Product) http://abbott.mediaroom.com/ Abbott Introduces the Afinion™ 2 Analyzer Rapid Test System for Diabetes Management http://abbott.mediaroom.com/2018-05-31-Abbott-Introduces-the-Afinion-TM-2-Analyzer-Rapid-Test-System-for-Diabetes-Management STATE-OF-THE-ART MULTI-ASSAY TEST SYSTEM HELPS PEOPLE WITH DIABETES GET THE HbA1c RESULTS THEY NEED WITHIN 3 MINUTES -- ALLOWING MORE TIME FOR CONSULTATION AND CARE DURING A SINGLE HEALTHCARE VISIT Thu, 31 May 2018 08:00:00 -0400 http://abbott.mediaroom.com/2018-05-31-Abbott-Introduces-the-Afinion-TM-2-Analyzer-Rapid-Test-System-for-Diabetes-Management Real-World Study Results Support Use of Abbott's AMPLATZER™ Amulet™ to Reduce Stroke in Patients Suffering from Atrial Fibrillation Without the Need for Lifetime Blood Thinners http://abbott.mediaroom.com/2018-05-24-Real-World-Study-Results-Support-Use-of-Abbotts-Amplatzer-Amulet-to-Reduce-Stroke-in-Patients-Suffering-From-Atrial-Fibrillation-Without-Need-For-Lifetime-Blood-Thinners - Study confirms safety of treatment with AMPLATZER Amulet device and reduction in stroke risk by nearly 60 percent Thu, 24 May 2018 09:59:00 -0400 http://abbott.mediaroom.com/2018-05-24-Real-World-Study-Results-Support-Use-of-Abbotts-Amplatzer-Amulet-to-Reduce-Stroke-in-Patients-Suffering-From-Atrial-Fibrillation-Without-Need-For-Lifetime-Blood-Thinners Newest Generation of Leading Heart Stent is Now Approved in the U.S. for People with Coronary Artery Disease http://abbott.mediaroom.com/2018-05-23-Newest-Generation-of-Leading-Heart-Stent-is-Now-Approved-in-the-U-S-for-People-with-Coronary-Artery-Disease - XIENCE Sierra™, the newest generation of XIENCE drug-eluting stents, received U.S. Food and Drug Administration (FDA) approval Wed, 23 May 2018 09:00:00 -0400 http://abbott.mediaroom.com/2018-05-23-Newest-Generation-of-Leading-Heart-Stent-is-Now-Approved-in-the-U-S-for-People-with-Coronary-Artery-Disease Abbott's Investigational Tendyne™ Device for Mitral Valve Replacement Demonstrates Positive Outcomes at 30 Days in Global Study http://abbott.mediaroom.com/2018-05-23-Abbotts-Investigational-Tendyne-TM-Device-for-Mitral-Valve-Replacement-Demonstrates-Positive-Outcomes-at-30-Days-in-Global-Study - Promising results for Tendyne valve presented as late-breaking clinical trial at EuroPCR Wed, 23 May 2018 06:00:00 -0400 http://abbott.mediaroom.com/2018-05-23-Abbotts-Investigational-Tendyne-TM-Device-for-Mitral-Valve-Replacement-Demonstrates-Positive-Outcomes-at-30-Days-in-Global-Study Treatment with Abbott's Portico™ Transcatheter Aortic Valve Showed Portico is Safe and Reduces Severe Aortic Stenosis at 30 Days in Real-World Setting http://abbott.mediaroom.com/2018-05-22-Treatment-with-Abbotts-Portico-Transcatheter-Aortic-Valve - Data presented at EuroPCR indicated excellent clinical outcomes for Portico in a real-world setting to treat common and life-threatening heart valve disease with minimally invasive option Tue, 22 May 2018 07:27:00 -0400 http://abbott.mediaroom.com/2018-05-22-Treatment-with-Abbotts-Portico-Transcatheter-Aortic-Valve